|
KMID : 1149120200170010001
|
|
Journal of the Korean Society for Psoriasis
2020 Volume.17 No. 1 p.1 ~ p.4
|
|
|
COVID-19 and Psoriasis
|
|
Jang Yun-Kyung
Seok Seung-Hui
Kim Dong-Hyun
|
|
|
Abstract
|
|
|
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARSCoV- 2) virus, has been spreading worldwide since December 2019. Most of COVID-19 patients exhibit mild-to-moderate symptoms and recover without sequelae, however some patients progress to acute respiratory distress syndrome or multiple organ failure, associated with high mortality.
Psoriasis is chronic inflammatory disease represented by innate and adaptive immune dysregulation, which is targeted by immunomodulatory therapies. There is uncertainty concerning the outcome of COVID-19 infection in psoriasis patients who are receiving conventional immunosuppressive medications or biologic therapies. In this review, we will discuss about what dermatologists need to aware of and what we can help patients as dermatologists.
|
|
|
KEYWORD
|
|
|
Coronavirus disease 19, Psoriasis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|